全文获取类型
收费全文 | 4744篇 |
免费 | 309篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 72篇 |
儿科学 | 96篇 |
妇产科学 | 75篇 |
基础医学 | 592篇 |
口腔科学 | 176篇 |
临床医学 | 423篇 |
内科学 | 991篇 |
皮肤病学 | 37篇 |
神经病学 | 313篇 |
特种医学 | 180篇 |
外科学 | 755篇 |
综合类 | 195篇 |
一般理论 | 10篇 |
预防医学 | 370篇 |
眼科学 | 45篇 |
药学 | 345篇 |
中国医学 | 74篇 |
肿瘤学 | 351篇 |
出版年
2023年 | 60篇 |
2022年 | 56篇 |
2021年 | 122篇 |
2020年 | 100篇 |
2019年 | 106篇 |
2018年 | 126篇 |
2017年 | 123篇 |
2016年 | 119篇 |
2015年 | 100篇 |
2014年 | 158篇 |
2013年 | 237篇 |
2012年 | 320篇 |
2011年 | 318篇 |
2010年 | 173篇 |
2009年 | 131篇 |
2008年 | 261篇 |
2007年 | 281篇 |
2006年 | 264篇 |
2005年 | 257篇 |
2004年 | 325篇 |
2003年 | 295篇 |
2002年 | 309篇 |
2001年 | 156篇 |
2000年 | 101篇 |
1999年 | 49篇 |
1998年 | 49篇 |
1997年 | 44篇 |
1996年 | 32篇 |
1995年 | 32篇 |
1994年 | 26篇 |
1993年 | 38篇 |
1992年 | 21篇 |
1991年 | 26篇 |
1990年 | 24篇 |
1989年 | 21篇 |
1988年 | 16篇 |
1987年 | 13篇 |
1986年 | 18篇 |
1985年 | 13篇 |
1984年 | 16篇 |
1983年 | 16篇 |
1982年 | 10篇 |
1980年 | 9篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1973年 | 15篇 |
1972年 | 8篇 |
1971年 | 6篇 |
1969年 | 7篇 |
排序方式: 共有5100条查询结果,搜索用时 15 毫秒
81.
Anton Pottegård Ann-Katrine Kviesgaard Ulrik Hesse Søren Ilsøe Moreno Jane Møller Hansen 《International journal of clinical pharmacy》2014,36(4):693-696
Background Use of over-the-counter (OTC) high-dose acetylsalicylic acid (ASA) is a risk factor for experiencing gastric bleeding. However, more detailed knowledge on the characteristics of users of OTC ASA is needed. Objective To characterise users of OTC high-dose ASA in a Danish pharmacy setting. Method We conducted an interview based survey among users of OTC high-dose ASA. Questions were asked regarding: (1) demographic characteristics; (2) use patterns; (3) knowledge about adverse events; (4) risk factors for experiencing gastric bleeding; (5) reasons for choosing an ASA-containing medicine; and (6) whether their GP was informed on their use of high-dose ASA. Results One-hundred-seventeen interviews were completed. Nineteen percent and 37 % used high-dose ASA on a daily or weekly basis respectively. Sixty-eighth percent found high-dose ASA to be more effective than other analgesics. Fourty-seven percent had one or more risk factors for experiencing ulcer bleeding, most commonly age >60 years (32 %) and previous peptic ulcer (9 %). The most well-known adverse events were abdominal pain (32 %) and peptic ulcer (26 %). The most common source of information was friends and family (32 %). Conclusion A large proportion of users of high-dose ASA have risk factors for experiencing gastric bleeding. Health-care professionals needs to provide more information on potential adverse events. 相似文献
82.
83.
84.
85.
Ole Dyg Pedersen Peter S?ndergaard Tonny Nielsen S?ren Junge Nielsen Eric Steen Nielsen Niels Falstie-Jensen Ingolf Nielsen Lars K?ber Hans Burchardt Marie Seibaek Christian Torp-Pedersen 《European heart journal》2006,27(23):2866-2870
AIMS: Atrial fibrillation (AF) is a risk factor for death in patients with a myocardial infarction, but highly variable results are reported in patients with heart failure. We studied the prognostic impact of AF in heart failure patients with and without ischaemic heart disease. METHODS AND RESULTS: During a period of 2 years, 3587 patients admitted to hospital because of heart failure were included in this study. All patients were examined by echocardiography and the presence of AF was recorded. Follow-up was available for 8 years. Twenty four percent of those discharged alive from hospital had AF. After 4 and 8 years of follow-up, mortality was higher in patients with AF than in patients without, 56 vs. 52% and 77 vs. 73%, respectively. Cox multivariable regression analysis showed a small but significant importance of AF for long-term mortality [hazard ratio (HR) 1.12, 95% confidence limits (CI), 1.02-1.23, P=0.018]. There was a significant interaction between the importance of AF and the presence of ischaemic heart disease (P=0.034). In patients with AF at the time of discharge and ischaemic heart disease, HR was 1.25 (95% CI: 1.09-1.42) and P<0.001; in patients with AF at discharge and without ischaemic heart disease, HR was 1.01 (95% CI: 0.88-1.16) and P=0.88. CONCLUSION: AF is associated with increased risk of death only in patients with ischaemic heart disease. This finding may explain the variable results of studies of the prognosis associated with AF in heart failure. 相似文献
86.
Acute effects of ghrelin administration on glucose and lipid metabolism 总被引:11,自引:0,他引:11
Vestergaard ET Djurhuus CB Gjedsted J Nielsen S Møller N Holst JJ Jørgensen JO Schmitz O 《The Journal of clinical endocrinology and metabolism》2008,93(2):438-444
CONTEXT: Ghrelin infusion increases plasma glucose and nonesterified fatty acids, but it is uncertain whether this is secondary to the concomitant release of GH. OBJECTIVE: Our objective was to study direct effects of ghrelin on substrate metabolism. DESIGN: This was a randomized, single-blind, placebo-controlled two-period crossover study. SETTING: The study was performed in a university clinical research laboratory. PARTICIPANTS: Eight healthy men aged 27.2 +/- 0.9 yr with a body mass index of 23.4 +/- 0.5 kg/m(2) were included in the study. INTERVENTION: Subjects received infusion of ghrelin (5 pmol x kg(-1) x min(-1)) or placebo for 5 h together with a pancreatic clamp (somatostatin 330 microg x h(-1), insulin 0.1 mU x kg(-1) x min(-1), GH 2 ng x kg(-1) x min(-1), and glucagon 0.5 ng.kg(-1) x min(-1)). A hyperinsulinemic (0.6 mU x kg(-1) x min(-1)) euglycemic clamp was performed during the final 2 h of each infusion. RESULTS: Basal and insulin-stimulated glucose disposal decreased with ghrelin [basal: 1.9 +/- 0.1 (ghrelin) vs. 2.3 +/- 0.1 mg x kg(-1) x min(-1), P = 0.03; clamp: 3.9 +/- 0.6 (ghrelin) vs. 6.1 +/- 0.5 mg x kg(-1) x min(-1), P = 0.02], whereas endogenous glucose production was similar. Glucose infusion rate during the clamp was reduced by ghrelin [4.0 +/- 0.7 (ghrelin) vs. 6.9 +/- 0.9 mg.kg(-1) x min(-1); P = 0.007], whereas nonesterified fatty acid flux increased [131 +/- 26 (ghrelin) vs. 69 +/- 5 micromol/min; P = 0.048] in the basal period. Regional lipolysis (skeletal muscle, sc fat) increased insignificantly with ghrelin infusion. Energy expenditure during the clamp decreased after ghrelin infusion [1539 +/- 28 (ghrelin) vs. 1608 +/- 32 kcal/24 h; P = 0.048], but the respiratory quotient did not differ. Minor but significant elevations in serum levels of GH and cortisol were observed after ghrelin infusion. CONCLUSIONS: Administration of exogenous ghrelin causes insulin resistance in muscle and stimulates lipolysis; these effects are likely to be direct, although a small contribution of GH and cortisol cannot be excluded. 相似文献
87.
D. Tobüren 《Journal of cancer research and clinical oncology》1981,102(2):189-193
Summary The cytotoxic effect of bleomycin (BLM) on Chinese hamster V79-cells grown as spheroids is compared to that on monolayer cultures in exponential vs. plateau phase of growth. Cells treated as intact spheroids with BLM (50 g/ml for 1 h) are more sensitive than monolayer cultures. Cell subpopulations derived from different zones of the spheroids survive BLM-treatment to different degrees: When treated as single cells in suspension, the formerly outer cells are less affected than the inner cells. Within intact spheroids, however, progressive cellular resistance with increasing distance from the outer rim is found. 相似文献
88.
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies 总被引:1,自引:0,他引:1 下载免费PDF全文
89.
刚地弓形虫RH株GRA6分子基因克隆与序列分析 总被引:1,自引:0,他引:1
目的 克隆刚地弓形虫 RH株致密颗粒抗原 (Dense granule antigen,GRA6 )分子基因 ,为研究使用重组的GRA6分子作为抗原进行弓形虫病诊断奠定基础。 方法 根据己知的 GRA6序列合成一对引物 ,抽提弓形虫速殖子m RNA,以速殖子 m RNA为模板 ,通过反转录 PCR(RT- PCR)扩增出 GRA6的 c DNA条带。目的基因 DNA条带被克隆到质粒 p UC19中形成重组质粒。对重组质粒 DNA进行纯化 ,并对目的基因片段进行核苷酸序列分析。 结果 通过RT- PCR从 m RNA中扩增出一条分子量约 70 0 bp的 DNA条带。核苷酸序列分析表明 ,GRA6分子基因的开放的阅读框全长为 6 93bp,编码 2 30个氨基酸分子 ,与已报道的 RH株 GRA6分子具有 10 0 %的同源性。 结论 本研究获得了刚地弓形虫 RH株的 GRA6分子基因 ,为今后应用此分子作为抗原诊断弓形虫病奠定了基础 相似文献
90.
Buntzen S Rasmussen OO Ryhammer AM Sørensen M Laurberg S Christiansen J 《Diseases of the colon and rectum》2004,47(8):1409-1411
Fecal incontinence is a common condition that causes major impairment of social life. Sacral nerve stimulation is a promising treatment in idiopathic fecal incontinence when conventional treatments have failed. However, new indications for sacral nerve stimulation are emerging. The present case shows that sacral nerve stimulation for treatment of fecal incontinence may be justified in other diseases in which fecal incontinence is a major problem. 相似文献